Delayed Recovery and Insufficient Proceeds from Unlisted Investments
First written in FY2025. 2 of 3 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2018: 3 of 9 companies on the "Worse" side.
10 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The failure of investee companies, delays in listings, or weak selling prices after listing may result in losses on sales or longer recovery periods, potentially adversely affecting operating results and financial position.」
The risk of delayed or insufficient recovery of unlisted investments and countermeasures including M&A and sales to third parties other than through IPOs remain. - FY2026-H1RestatedAnnual report
「During the interim consolidated accounting period under review, there were no significant changes in the matters described in this interim report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
It states that there were no material changes from the previous fiscal year regarding the risk of delayed or insufficient recovery of unlisted investments. - FY2025First statedAnnual report
「The failure of investee companies, delays in listings, or weak selling prices after listing may result in losses on sales or longer recovery periods, potentially adversely affecting operating results and financial position.」
The company cites monitoring of investee companies, M&A and sales to third parties other than through IPOs, management support, and portfolio diversification as countermeasures.